We are very happy to announce that we already have Gabriela Garrastazu with us as a Project Leader. The DIVERSA team keeps growing! Gabriela's professional path She has been devoted to nanoparticle research, where she has participated in numerous collaborative research projects. Some of [...]
PARTICIPAMOS EN EL PROGRAMA INNOVAPEME con nuestro PLAN DE INNOVACIÓN DIVERSA TECHNOLOGIES 2022-2023 DIVERSA Technologies, S.L. ha puesto en marcha su Plan de Innovación de cara a las anualidades 2022-2023. Este plan está subvencionado por la AXENCIA GALEGA DE INNOVACIÓN (GAIN) dentro de la aplicación [...]
DIVERSA has been awarded the prestigious award by the “Deputación da Coruña” among several emerging companies. The rationale of PEL awards The PEL awards are part of the Local Employment Plan of the “Deputación da Coruña”. It is a strong commitment to entrepreneurship, [...]
Our CEO and co-founder Maria de la Fuente received the Title of Galician Excellence from the Association of Galician Entrepreneurs in Catalonia. Already contributing to economic development The Association of Galician Entrepreneurs in Catalonia held its annual gala, an event in which the [...]
DIVERSA has been selected under the ICEX NEXT program on a competitive basis amongst more than 150 Spanish SMEs, and here we tell you how this opportunity could help us be more competitive internationally. What is ICEX NEXT? The Foreign Trade Institute (ICEX), [...]
We are happy to share that Laura Taina González, our PhD student, had the opportunity to join Vaccine Design and Delivery (VDD). VDD is a group led by Professor Camilla Foged at University of Copenhagen. Laura is doing her industrial PhD at DIVERSA and is [...]
In February 2022, a month after DIVERSA’s incorporation, commercial activities for the company will start at large with the launch into market of our ready-to-go kits. Specifically for the European Union and United Kingdom markets. The commercialization will be supported by the French distributor [...]
The spin-off co-founded by María de la Fuente, Abi Judit Vázquez and Rafael López, participated by the Health Research Institute of Santiago de Compostela (IDIS) and the Galician Healthcare System (SERGAS), and incorporated in January 2022, goes to market with the aim of commercializing [...]
